
As international travel continues to be a regular part of life for many, travellers are increasingly exploring destinations across Asia and the Western Pacific. However, one critical aspect of travel health that is often overlooked is protection against Japanese Encephalitis (JE). Reflecting on current search trends, we find that many travellers have questions about this vaccine. This article provides insights from a travel health perspective to address these common concerns.
Japanese Encephalitis is an acute infectious disease caused by the Japanese Encephalitis virus. It is primarily transmitted through the bite of infected mosquitoes, specifically Culex tritaeniorhynchus. The disease is most commonly found in rural and agricultural areas across Asia and the Western Pacific, including Japan, Taiwan, South Korea, Thailand, and Vietnam.
Most infected individuals show no symptoms, but about 1 in 250 people may develop severe symptoms, including:
Children and the elderly are more vulnerable to severe complications, which can sometimes lead to permanent neurological damage.
While most infections are mild, the consequences can be serious once encephalitis (inflammation of the brain) develops. We recommend travellers to high-risk areas plan ahead for prevention and vaccination.
In Hong Kong, the available JE vaccine is the live attenuated Imojev (Substipharm). Below are the recommended vaccination schedule:
| Group | Primary Dose | Booster Recommendation |
|---|---|---|
| 9 months–17 years | One dose (subcutaneous) | A booster is recommended 12–24 months after the primary dose |
| 18 years and above | One dose (subcutaneous) | Generally not required |
If your itinerary is limited to urban areas with air-conditioned accommodations and good mosquito protection, the risk is relatively low. However, if you plan to visit suburban attractions, temples, parks, or travel during the rainy season, vaccination is recommended for added protection.
Most people experience only mild reactions, such as redness or swelling at the injection site, low-grade fever, or tiredness, which usually subside within 1–2 days. Severe allergic reactions are very rare.
Shoebill Health Care offers Japanese Encephalitis vaccination. For detailed information on vaccine availability and pricing, please visit our Vaccine Information Page. To book an appointment, you can use our Online Booking System.
We provide tailored advice based on your destination, itinerary, duration of stay, and personal health profile. For example:
Even after vaccination, you should still take mosquito precautions in risk areas:
Japanese Encephalitis is just one aspect of travel health. We also recommend reviewing:
As travel options continue to expand, so should our approach to health preparation. Vaccination against Japanese Encephalitis isn’t just a yes-or-no decision—it’s a health investment that should be carefully planned according to your itinerary. We recommend that travellers to JE risk areas schedule their vaccination at least two weeks before departure.
If you would like to book a vaccination appointment, please visit our Online Booking Page to arrange an appointment. Wishing you safe and enjoyable travels.